Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

This study has been terminated.

( For business reasons )

Study NCT00083564 Information provided by Poniard Pharmaceuticals

First Received: May 25, 2004 Last Updated: March 30, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given